chitosan has been researched along with su 11248 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Gomathi, T; Joseph, JJ; Sangeetha, D | 1 |
Atyabi, F; Bahrainian, S; Dinarvand, R; Saber, MM | 1 |
Karimi, MH; Mahdavinia, GR; Massoumi, B | 1 |
Atlasi, Z; Hadifar, S; Jafari, H; Mahdavinia, GR; Sabzi, M | 1 |
Jafari, H; Mahdavinia, GR; Namazi, H | 1 |
5 other study(ies) available for chitosan and su 11248
Article | Year |
---|---|
Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
Topics: Angiogenesis Inhibitors; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Indoles; Kinetics; Nanoparticles; Particle Size; Pyrroles; Spectroscopy, Fourier Transform Infrared; Sunitinib; X-Ray Diffraction | 2016 |
Targeted drug delivery of Sunitinib Malate to tumor blood vessels by cRGD-chiotosan-gold nanoparticles.
Topics: Cell Survival; Cells, Cultured; Chitosan; Drug Carriers; Drug Liberation; Gold; Humans; Indoles; Nanoparticles; Neoplasms; Particle Size; Peptides, Cyclic; Pyrroles; Sunitinib; Surface Properties | 2017 |
pH-controlled sunitinib anticancer release from magnetic chitosan nanoparticles crosslinked with κ-carrageenan.
Topics: Antineoplastic Agents; Carrageenan; Chitosan; Cross-Linking Reagents; Drug Carriers; Drug Liberation; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Indoles; Magnetite Nanoparticles; Pyrroles; Spectroscopy, Fourier Transform Infrared; Sunitinib; Surface Properties; X-Ray Diffraction | 2018 |
Magnetic κ-carrageenan/chitosan/montmorillonite nanocomposite hydrogels with controlled sunitinib release.
Topics: Bentonite; Carrageenan; Chitosan; Drug Carriers; Drug Liberation; Hydrogels; Hydrogen-Ion Concentration; Magnetic Phenomena; Nanogels; Sunitinib | 2021 |
pH-sensitive biocompatible chitosan/sepiolite-based cross-linked citric acid magnetic nanocarrier for efficient sunitinib release.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Chitosan; Citric Acid; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Magnetic Phenomena; Magnetite Nanoparticles; Staphylococcus aureus; Sunitinib | 2023 |